Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

This publication has 10 references indexed in Scilit:

• Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
  The Lancet, 2020
• Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis
  Published by Elsevier ,2020
• COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland
  Intensive Care Medicine, 2020
• Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
  The Lancet, 2020
• A minimal common outcome measure set for COVID-19 clinical research
  The Lancet Infectious Diseases, 2020
• Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
  The Lancet, 2020
• Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
  Published by Elsevier ,2020
• Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
  The Lancet, 2020
• Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial
  BMJ, 2015
• A Modified Poisson Regression Approach to Prospective Studies with Binary Data
  American Journal of Epidemiology, 2004